Toxicologic pathology of the liver has always been of special importance due to the frequency of toxicities in this organ. The central role of the liver in metabolizing xenobiotics puts the liver at special risk to injury despite the numerous protective mechanisms present to prevent or reduce toxicity. The liver is relatively simple as judged by macroscopic and microscopic anatomy. This apparent simplistic structure has led some observers to believe that the liver has a very restricted array of responses to injury. Indeed, the types of responses are numerous and the mechanisms of responses are exceedingly complex.
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Toxicologic pathology of the liver traditionally has a morphologic basis. Advancements in the characterization of lesions and standardization of nomenclature have been significant in the last 15 years. The nomenclature of rodent tumors of hepatocytic origin is highly standardized amongst toxicologic pathologists today. While consistency of diagnosis is important for communication among pathologists and between pathologists and toxicologists, the toxicologic pathologist has the responsibility to relate to many different audiences the relevance of the animal toxicity to potentially exposed humans. To meet this responsibility, the modern toxicologic pathologist must have an understanding of the mechanism of xenobiotic-induced lesions.
Marked scientific advances are being made daily to provide the toxicologic pathologists with a better understanding of the cellular, biochemical, and molecular events that underlie hepatic toxicity. These advances include technical approaches such as magnetic resonance imaging and special staining procedures that are described in this volume. The evolution of our understanding of xenobiotic metabolism and the relationship of that metabolism to toxicity continues to expand at an exponential pace. Molecular biology has advanced beyond the level of descriptive biology to mechanistic toxicology and toxicologic pathology in a few short years. A number of papers in this volume describe the use of molecular biology techniques that are providing important information to the toxicologic pathologist. The current explosion of information based on molecular biology approaches will certainly continue in the future, thereby providing important mechanistic understanding that affects the interpretation of the relevance of animal toxicity for predicting effects in exposed humans.
Classically, considerations of hepatic toxic effects focused almost exclusively on the hepatocyte. Fascinating information has been published in the last decade on the toxic responses of nonhepatocytic cells of the liver. The bile duct epithelium has received significant attention in recent years, resulting in a better understanding of the basis for different bile duct responses to injury as described in several of the articles in this volume. While attention to injury of the sinusoidal lining cells has also greatly expanded, the advancements in the understanding of the interaction of these cells with hepatocyte deserve special recognition. Information outlined in this volume indicates that the nonparenchymal cells have significant impact on the toxicologic response of the hepatocytes. Clearly, the liver is now properly being viewed as a complex organ composed of different cell types that affect the physiology and toxic responses of each other.
Rodent liver tumors continue to garner special interest due to the relative frequency of this tumor type compared to other tumor types in rodent bioassays. Techniques for defining the multiple steps in carcinogenesis have greatly advanced, allowing an analysis of the effects of specific xenobiotics on defined stages of tumor development. The implications of these advances for human risk assessment deserve special attention in the near future.
The series of papers in this issue of Toxicologic Pathology are derived from presentations made at the 14th International Symposium sponsored by the Society of Toxicologic Pathologists. The papers continue the intention of the symposium by providing concise reviews of scientific adB ances in hepatic injury. This information provides basic information that is useful to the Experimental pathutogist that needs an introduction to a specific topic. The information in these papers also pré 1B ldc, a background for the murphutugic pathologist to identify new approaches that will enhance the diagnostic procedures and terminology being used and to provide information that will enhance the understanding of the mechanism underlying specific morphologic responses. The enhancement of diagnostic procedures and the understanding of the basis for the lesion are indispensable components for the current toxicologic pathologist to meet the responsibility of interpreting the relevance of animal toxicities for predicting potential toxicities in humans.
